Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy-Reference-Cited by-同舟云学术

Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy

Published:2022 Issue: Volume:32 Page:100603
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Caliman Enrico,Fancelli Sara,Ottanelli Carlotta,Mazzoni Francesca,Paglialunga Luca,Lavacchi Daniele,Michelet Marta Rita Gatta,Giommoni Elisa,Napolitano Brunella,Scolari Federico,Voltolini Luca,Comin Camilla Eva,Pillozzi Serena,Antonuzzo Lorenzo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

2. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020

3. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017

4. Immunotherapy in non-small cell lung cancer: facts and hopes;Doroshow;Clin. Cancer Res.,2019

5. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC);Brahmer;J. Immunother. Cancer,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy;Human Vaccines & Immunotherapeutics;2024-09-13

2. Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours;Clinical and Translational Medicine;2024-08

3. Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative Review of Challenges and Opportunities;Cancers;2024-04-15

4. Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade;Journal of Experimental & Clinical Cancer Research;2024-03-16

5. Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors;Journal of Cancer Research and Clinical Oncology;2024-02-21